Adage Capital Partners’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $216M | Sell |
|
|||||
|
2025
Q1 | $195M | Sell |
|
|||||
|
2024
Q4 | $433M | Buy |
|
|||||
|
2024
Q3 | $337M | Buy |
|
|||||
|
2024
Q2 | $288M | Buy |
|
|||||
|
2024
Q1 | $329M | Sell |
|
|||||
|
2023
Q4 | $306M | Buy |
|
|||||
|
2023
Q3 | $267M | Buy |
|
|||||
|
2023
Q2 | $266M | Buy |
|
|||||
|
2023
Q1 | $261M | Buy |
|
|||||
|
2022
Q4 | $277M | Sell |
|
|||||
|
2022
Q3 | $328M | Sell |
|
|||||
|
2022
Q2 | $702M | Sell |
|
|||||
|
2022
Q1 | $968M | Hold |
|
|||||
|
2021
Q4 | $990M | Buy |
|
|||||
|
2021
Q3 | $893M | Buy |
|
|||||
|
2021
Q2 | $931M | Sell |
|
|||||
|
2021
Q1 | $1.08B | Sell |
|
|||||
|
2020
Q4 | $1.94B | Sell |
|
|||||
|
2020
Q3 | $1.94B | Hold |
|
|||||
|
2020
Q2 | $2.23B | Buy |
|